Volume 15, Issue 1, Pages (January 2014)

Slides:



Advertisements
Similar presentations
Chapter 85: Treatment and Prevention of Bone Metastases and Myeloma Bone Disease Jean-Jacques Body.
Advertisements

Fever of unknown origin and cancer: a population-based study
Volume 14, Issue 4, Pages (April 2013)
Volume 16, Issue 8, Pages (August 2015)
Volume 385, Issue 9980, Pages (May 2015)
Volume 380, Issue 9846, Pages (September 2012)
Volume 364, Issue 9440, Pages (September 2004)
Volume 18, Issue 6, Pages (June 2017)
Volume 376, Issue 9747, Pages (October 2010)
Volume 18, Issue 7, Pages (July 2017)
Volume 16, Issue 9, Pages (September 2015)
Volume 376, Issue 9734, Pages (July 2010)
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Volume 372, Issue 9633, Pages (July 2008)
Managing Metastatic Bone Pain: The Role of Bisphosphonates
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 14, Issue 4, Pages (April 2013)
Volume 377, Issue 9783, Pages (June 2011)
Volume 373, Issue 9666, Pages (March 2009)
Volume 16, Issue 13, Pages (October 2015)
Volume 376, Issue 9734, Pages (July 2010)
Volume 9, Issue 5, Pages (May 2008)
Volume 13, Issue 3, Pages (March 2012)
Volume 14, Issue 3, Pages (March 2013)
Volume 372, Issue 9633, Pages (July 2008)
Volume 12, Issue 9, Pages (September 2013)
Volume 373, Issue 9677, Pages (May 2009)
Volume 15, Issue 4, Pages (April 2014)
Volume 376, Issue 9757, Pages (December 2010)
Aspirin in the prevention of cancer – Author's reply
Volume 14, Issue 10, Pages (September 2013)
Volume 385, Issue 9966, Pages (January 2015)
Volume 374, Issue 9707, Pages (December 2009)
Volume 10, Issue 6, Pages (June 2009)
Volume 373, Issue 9663, Pages (February 2009)
Volume 392, Issue 10147, Pages (August 2018)
Volume 15, Issue 4, Pages (April 2014)
Volume 9, Issue 10, Pages (October 2008)
Volume 18, Issue 7, Pages (July 2017)
Volume 12, Issue 7, Pages (July 2011)
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,
Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study  Sune F Nielsen, PhD, Prof Børge G Nordestgaard,
Volume 12, Issue 8, Pages (August 2011)
Volume 18, Issue 3, Pages (March 2017)
Volume 379, Issue 9812, Pages (January 2012)
Volume 382, Issue 9888, Pages (July 2013)
Volume 13, Issue 1, Pages (January 2012)
Volume 19, Issue 10, Pages (October 2018)
Volume 14, Issue 11, Pages (October 2013)
Volume 373, Issue 9666, Pages (March 2009)
Volume 385, Issue 9962, Pages (January 2015)
Volume 19, Issue 4, Pages (April 2018)
Volume 375, Issue 9709, Pages (January 2010)
Volume 373, Issue 9676, Pages (May 2009)
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 388, Issue 10055, Pages (October 2016)
Volume 14, Issue 6, Pages (May 2013)
Volume 5, Issue 4, Pages (April 2018)
Volume 375, Issue 9726, Pages (May 2010)
Volume 375, Issue 9714, Pages (February 2010)
Volume 11, Issue 1, Pages (January 2010)
Volume 376, Issue 9757, Pages (December 2010)
Volume 12, Issue 8, Pages (August 2011)
Volume 375, Issue 9715, Pages (February 2010)
Volume 376, Issue 9747, Pages (October 2010)
Volume 372, Issue 9632, Pages (July 2008)
Volume 5, Issue 1, Pages (January 2018)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid- stimulating hormone for differentiated thyroid cancer (HiLo): long-term results.
Volume 20, Issue 5, Pages (May 2019)
Volume 14, Issue 7, Pages (June 2013)
Presentation transcript:

Volume 15, Issue 1, Pages 114-122 (January 2014) Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial  Prof Peter Barrett-Lee, MD, Angela Casbard, MSc, Jacinta Abraham, FRCR, Prof Kerenza Hood, PhD, Prof Robert Coleman, MD, Peter Simmonds, FRACP, Hayley Timmins, BSc, Duncan Wheatley, FRCR, Robert Grieve, FRCR, Gareth Griffiths, PhD, Nick Murray, DPhil  The Lancet Oncology  Volume 15, Issue 1, Pages 114-122 (January 2014) DOI: 10.1016/S1470-2045(13)70539-4 Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile ITT=intention to treat. PP=per protocol. *Not all patients gave a reason and more than one reason could be given. The Lancet Oncology 2014 15, 114-122DOI: (10.1016/S1470-2045(13)70539-4) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 2 Risk difference of patients experiencing toxic effects (ibandronic acid–zoledronic acid) The Lancet Oncology 2014 15, 114-122DOI: (10.1016/S1470-2045(13)70539-4) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 3 Pain severity (A) and use of analgesics (B) during the study period Mean pain severity scores measured using the Brief Pain Inventory (BPI). Opioid use represents the percentage of patients reporting use of opioid and non-opioid analgesics at each visit, with 95% CIs. The Lancet Oncology 2014 15, 114-122DOI: (10.1016/S1470-2045(13)70539-4) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 4 Cumulative incidence of skeletal-related events (A) and of first skeletal-related event (B) in the per-protocol population The Lancet Oncology 2014 15, 114-122DOI: (10.1016/S1470-2045(13)70539-4) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 5 Cumulative incidence of skeletal-related events in the intention-to-treat population The Lancet Oncology 2014 15, 114-122DOI: (10.1016/S1470-2045(13)70539-4) Copyright © 2014 Elsevier Ltd Terms and Conditions

Figure 6 Overall survival in the intention-to-treat population The Lancet Oncology 2014 15, 114-122DOI: (10.1016/S1470-2045(13)70539-4) Copyright © 2014 Elsevier Ltd Terms and Conditions